# Ind-Swift Laboratories Ltd (INDSWFTLAB)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹135.35
Day Change: -0.39%
52W High: ₹156.5
52W Low: ₹70.7
Market Cap: ₹1,163 Cr

## Valuation
P/E: 3.88
P/B: 0.82
EPS: ₹34.49
Book Value: ₹163.64
Dividend Yield: 0%

## Returns
1Y Return: 28.89%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0.02
Revenue Growth: 1641.1%
Profit Growth: 107314.4%
EBITDA Margin: -8.68%
Operating Margin: -3.09%

## About
Ind-Swift Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Ind-Swift Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:59:06.345Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:06.345Z
Quant Updated: 2026-05-18T22:59:06.345Z
Sentiment Updated: 2026-05-18T22:59:06.345Z
Financials Status: current
Financials Updated: 2026-05-19T02:30:53.973Z
Financials Last Attempt: 2026-05-19T02:30:53.973Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹561.71 Cr
Operating Profit: ₹-41.64 Cr (OPM -7.41%)
Net Profit: ₹250.48 Cr
Tax: ₹7.27 Cr

## Annual P&L History
FY25: Rev ₹561.71Cr | PAT ₹250.48Cr | OPM -7.41%
FY24: Rev ₹1709.15Cr | PAT ₹538.75Cr | OPM 14.19%
FY23: Rev ₹1207.31Cr | PAT ₹47.6Cr | OPM 15.04%

## Balance Sheet (FY25)
Total Assets: ₹1438.34 Cr
Total Liabilities: ₹265.37 Cr
Borrowings: ₹40.86 Cr
Cash: ₹412.04 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Navrattan R. Munjal, Chairman & MD
- Himanshu  Jain BCom, Joint MD & Whole Time Director
- Gagan  Aggarwal, Chief Financial Officer
- Lalit  Goyal, Vice President of Accounts
- Pardeep  Verma, VP of Corporate Affairs, Compliance Officer & Company Secretary

---
Source: rupiya.io/stocks/indswftlab
Disclaimer: For research and education only. Not investment advice.